Delivery Order SPE2DE21D7009-SPE2D625F0USV
- Not listed
- Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corporation, was awarded a $1,867 fixed-price delivery order with economic price adjustment on September 9, 2025, for pain management medical devices. The contract is set to be completed by September 16, 2025, with performance taking place in Valencia, California. This delivery order is issued under Boston Scientific Neuromodulation's larger indefinite delivery contract (SPE2DE) with the Defense Logistics Agency Troop...
- Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corporation, has been awarded a delivery order valued at $41,430.34 for pain management medical devices and services. This fixed-price contract with economic price adjustment was awarded on September 9, 2025, with an ultimate completion date of September 19, 2025, and will be performed in Valencia, California. The award carries no set-aside designation, allowing the company to compete openly in the federal marketplace....
- Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corp, was awarded a $43,829.45 fixed-price delivery order with economic price adjustment for pain management medical devices on September 12, 2025, with an ultimate completion date of September 26, 2025. The contract, which carries no set-aside designation, is funded by the Medical Supply Chain, a defense-related procurement entity within the Department of Defense. Work will be performed at the contractor's facility in...
- Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corporation, was awarded a $23,176.50 fixed-price delivery order with economic price adjustment for pain management medical devices on August 20, 2025, with an ultimate completion date of August 27, 2025. This non-set-aside delivery order is funded by the Medical Supply Chain, a defense-related procurement entity within the Department of Defense, and will be performed in Valencia, California. The award represents a task...
- Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corporation, has been awarded a $26,980 fixed-price delivery order with economic price adjustment for pain management medical devices by the Medical Supply Chain, a defense-related procurement entity. The delivery order, issued on September 5, 2025, with an ultimate completion date of September 12, 2025, represents a child contract with no set-aside designation. Work will be performed at the contractor's facility in...
- Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corporation, was awarded a $30,564.10 fixed-price delivery order with economic price adjustment on August 29, 2025, for pain management medical devices and services. The contract, which carries no set-aside designation, is set to complete by September 8, 2025, and will be performed in Valencia, California. This delivery order is issued under Boston Scientific Neuromodulation's larger indefinite delivery contract with the...
- Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corp, was awarded a delivery order valued at $43,829.45 on September 9, 2025, for pain management medical devices and services. This fixed-price contract with economic price adjustment has a completion date of September 16, 2025, and will be performed in Valencia, California. The award carries no set-aside designation, allowing the company to compete openly in the federal marketplace. The contract is funded through the...
- Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corporation, has been awarded a fixed-price delivery order valued at $31,408.96 for pain management medical devices and equipment. The contract, awarded on July 24, 2025, with an ultimate completion date of July 31, 2025, carries no set-aside designation and will be performed in Valencia, California. The award is funded by the Medical Supply Chain, a defense-related procurement entity within the Department of Defense,...
- Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corporation, has been awarded a $1,867 fixed-price delivery order with economic price adjustment for pain management medical devices and services. The award, issued on August 19, 2025, with an ultimate completion date of August 26, 2025, represents a child contract under a larger indefinite delivery vehicle. Work will be performed in Valencia, California. This delivery order falls under the company's significant...
- Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corp, received a $43.7K fixed-price delivery order with economic price adjustment for pain management medical devices, awarded September 9, 2025, with completion targeted for September 19, 2025. The award was issued by the Medical Supply Chain, a defense-related procurement entity within the Department of Defense, with performance to occur at the contractor's Valencia, California facility. This delivery order carries no...
- SPE2DE21D7009Indefinite Delivery Contract
- SPE2DE21D7009-SPE2D625F0USVDelivery Order
Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corporation, received a $31,771.22 fixed-price delivery order with economic price adjustment for pain management medical devices on August 6, 2025, with completion targeted for August 13, 2025. The award was issued without set-aside designation by the Medical Supply Chain, a defense-related procurement entity within the Department of Defense. Work will be performed in Valencia, California. This delivery order represents a task order issued under Boston Scientific Neuromodulation's larger indefinite delivery contract (SPE2DE) with the Defense Logistics Agency Troop Support Medical branch, valued at approximately $83.1 million through August 2026. Boston Scientific Neuromodulation specializes in advanced neuromodulation therapies and non-opioid pain management solutions for service members and veterans, including spinal cord stimulation systems, implantable pain pumps, and radiofrequency ablation devices. The company's federal contract portfolio demonstrates consistent delivery of pain management technologies to military treatment facilities and Veterans Affairs medical centers nationwide. This delivery order supports the Department of Defense's objectives to provide innovative pain management alternatives to opioid-based therapies for personnel managing chronic pain from traumatic injuries.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $31.8k | 8/6/25 |